Omnicef and Famotidine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Omnicef (cefdinir) and Famotidine (famotidine). Common drug interactions include hiatus hernia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Omnicef and Famotidine. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Omnicef?
Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.
What is Famotidine?
Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,423 Famotidine users. Check the latest studies of Famotidine.
37 people who take Omnicef and Famotidine together, and have interactions are studied.

What are the common drug interactions of Omnicef and Famotidine, by gender? *:
female:
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- International normalised ratio increased
- Melaena (the passage of black, tarry stools)
- Migraine (headache)
- Nausea (feeling of having an urge to vomit)
- Nephropathy (damage to or disease of a kidney)
- Overdose
- Pancreatitis (inflammation of pancreas)
- Renal disorder (kidney disease)
- Renal failure chronic (long lasting kidney dysfunction)
male:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Ankle fracture
- Anxiety
- Aphonia (inability to produce voice)
- Arrhythmia (irregular heartbeat)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Asthenia (weakness)
- Asthma
- Attention deficit/hyperactivity disorder
What are the common drug interactions of Omnicef and Famotidine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
10-19:
n/a
20-29:
- Overdose
- Pancreatitis (inflammation of pancreas)
- Type 2 diabetes mellitus
- Influenza like illness
- Migraine (headache)
- Pancreatitis acute (sudden inflammation of pancreas)
30-39:
- Chronic kidney disease
- Pulmonary embolism (blockage of the main artery of the lung)
- Renal failure (kidney dysfunction)
40-49:
- Colitis haemorrhagic (bleeding diarrhoea due to infection of colon)
- Acute circulatory failure (shock)
- Chronic kidney disease
- Diarrhoea
- Haemorrhage (bleeding)
- International normalised ratio increased
- Melaena (the passage of black, tarry stools)
- Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
- Renal failure (kidney dysfunction)
- Renal tubular necrosis (death of kidney tubules)
50-59:
- Blood pressure systolic increased
- Coma (state of unconsciousness lasting more than six hours)
- Drooling (drop saliva uncontrollably from the mouth)
- Drug hypersensitivity
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Heart rate decreased
- Oedema peripheral (superficial swelling)
- Pneumonia
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Swollen tongue (swelling of tongue)
60+:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
- Nausea (feeling of having an urge to vomit)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Nephropathy (damage to or disease of a kidney)
- Tardive dyskinesia (a disorder that involves involuntary movements)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Abdominal adhesions (inflammation of abdomen)
- Abdominal distension
What are the existing conditions these people have? *
- Diabetes: 9 people, 24.32%
- High Blood Cholesterol: 9 people, 24.32%
- Depression: 8 people, 21.62%
- High Blood Pressure: 6 people, 16.22%
- Pain: 5 people, 13.51%
- Stress And Anxiety: 4 people, 10.81%
- Sleep Disorder: 3 people, 8.11%
- Infection: 3 people, 8.11%
- Insomnia (sleeplessness): 3 people, 8.11%
- Nausea (feeling of having an urge to vomit): 3 people, 8.11%
* Approximation only. Some reports may have incomplete information.
Do you take Omnicef and Famotidine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Omnicef (2,774 reports)
- Famotidine (83,423 reports)
Browse all drug interactions of Omnicef and Famotidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omnicef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Famotidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omnicef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Famotidine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefdinir and famotidine (the active ingredients of Omnicef and Famotidine, respectively), and Omnicef and Famotidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cefobid cause Chills? - 2 seconds ago
- Allergic Respiratory Symptom and Drug Dependence - 4 seconds ago
- Could Lactulose cause Anal Fissure? - 8 seconds ago
- Feverfew vs. Trazodone Hydrochloride, side effect and effectiveness comparison - 8 seconds ago
- Drug interactions of Intuniv and Dayvigo - 10 seconds ago
- Drug interactions of Mobic and Aranesp - 25 seconds ago
- Could Prednisone cause Loss Of Bladder Sensation? - 33 seconds ago
- Restless Leg Syndrome in Claritin Reditabs, how severe and when it was recovered? - 36 seconds ago
- Drug interactions of Tamsulosin and Zoledronic - 39 seconds ago
- Qvar and Acute Kidney Failure for Men aged 50-59 - 44 seconds ago